Advanced Cell Technology, Inc. , a leader in the field of regenerative medicine, announced today that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has announced a positive opinion of ACT’s human embryonic st…
ACT Receives Positive Opinion For Orphan Drug Designation From European Medicines Agency For HESC-Derived RPE Cells For Treatment Of Stargardt’s Disease
Advanced Cell Technology, Inc. , a leader in the field of regenerative medicine, announced today that the Committee for Orphan Medicinal Products (COMP) of the European Medicines Agency (EMA) has announced a positive opinion of ACT’s human embryonic st…
FDA accepts Merck’s SAFLUTAN NDA for standard review
Merck, known as MSD outside the United States and Canada, announced today that the New Drug Application for SAFLUTAN, Merck’s investigational preservative-free prostaglandin analogue ophthalmic solution, has been accepted for standard review by the U.S…
Tripartite International Research for the Elimination of Trachoma
Status: Recruiting,
Condition Summary: Trachoma; Chlamydia Infections
Plug-and-Play Macroscopes
FDA Approves New Cataract Multifocal Intraocular Lens From Abbott
Des Plaines, Illinois – Abbott (NYSE: ABT) announced today it has received U.S. Food and Drug Administration (FDA) approval for the TECNIS® Multifocal 1-Piece intraocular lens (IOL) for cataract patients with and without presbyopia.